PharmacyCodes



Labetalolum [INN-Latin] en es it fr

Labetalolum [INN-Latin] Brand names, Labetalolum [INN-Latin] Analogs

Labetalolum [INN-Latin] Brand Names Mixture

  • No information avaliable

Labetalolum [INN-Latin] Chemical_Formula

C8H14N2O2

Labetalolum [INN-Latin] RX_link

http://www.rxlist.com/cgi/generic3/keppra.htm

Labetalolum [INN-Latin] fda sheet

Labetalolum_[INN-Latin] FDA

Labetalolum [INN-Latin] msds (material safety sheet)

Labetalolum [INN-Latin] Synthesis Reference

No information avaliable

Labetalolum [INN-Latin] Molecular Weight

170.209 g/mol

Labetalolum [INN-Latin] Melting Point

No information avaliable

Labetalolum [INN-Latin] H2O Solubility

No information avaliable

Labetalolum [INN-Latin] State

No information avaliable

Labetalolum [INN-Latin] LogP

-0.523

Labetalolum [INN-Latin] Dosage Forms

Tablet

Labetalolum [INN-Latin] Indication

Used as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy.

Labetalolum [INN-Latin] Pharmacology

No information avaliable

Labetalolum [INN-Latin] Absorption

Rapidly and almost completely absorbed after oral administration (99%). Peak plasma concentrations occurring in about an hour following oral administration in fasted subjects.

Labetalolum [INN-Latin] side effects and Toxicity

Side effects include aggression, agitation, coma, drowsiness, reduced consciousness, slowed breathing

Labetalolum [INN-Latin] Patient Information

Labetalolum [INN-Latin] Organisms Affected

Humans and other mammals